Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...

Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, targeting a $447 ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Read also: Aurobindo Pharma arm terminates agreement with Hilleman Labs Singapore for pentavalent vaccine “With the positive Phase 1 study results, we are optimistic about our ongoing Phase 3 study.

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved ...

Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5mg, the generic equivalent of Janssen ...

An inhalers and derma products manufacturing plant of Aurobindo Pharma subsidiary Aurolife Pharma LLC in the U.S. has been issued 11 observations by the United States Food and Drug Administration.